The gut-brain axis has long been a subject of interest in lifespan research, and GLP-1 agonists, already used in the treatment of obesity and diabetes, are showing promise in the field of healthspan therapeutics.
New research on gut-to-brain signaling uncovers potential links between gut hormones like GLP-1 and longevity.
Leave a reply